LEGEND STRAT (01355) Income Statement & Earnings

0.139
+0.014+11.20%

Market Closed Apr 24 15:21 CST

165.84MMarket Cap-3.86P/E (TTM)

LEGEND STRAT (01355) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

26.11%51.31M

33.19%25.45M

-39.87%40.68M

-37.41%19.1M

7.40%67.66M

-4.14%30.52M

-10.72%63M

10.92%31.84M

39.24%70.56M

146.07%28.71M

Operating income

26.11%51.31M

33.19%25.45M

-39.87%40.68M

-37.41%19.1M

7.40%67.66M

-4.14%30.52M

-10.72%63M

10.92%31.84M

39.24%70.56M

146.07%28.71M

Cost of sales

-2,196.34%-17.57M

---8.44M

---765K

----

Operating expenses

-2,196.34%-17.57M

-8.44M

-765K

Gross profit

-15.48%33.74M

17.01M

39.92M

Employee expense

-7.58%-17.15M

13.03%-7.25M

10.04%-15.94M

23.01%-8.33M

17.90%-17.72M

5.17%-10.82M

-1.14%-21.59M

-1.77%-11.41M

-47.12%-21.34M

-66.18%-11.21M

Depreciation and amortization

42.88%-13.72M

39.78%-7.37M

17.61%-24.03M

17.49%-12.23M

4.85%-29.16M

8.79%-14.82M

-1.78%-30.65M

-15.23%-16.25M

-44.62%-30.11M

-60.69%-14.11M

Revaluation surplus

----

-7.94%-2.01M

-81.38%46K

-231.08%-1.86M

412.66%247K

-48.27%1.42M

---79K

--2.75M

----

-Changes in the fair value of financial assets

----

-7.94%-2.01M

-81.38%46K

-231.08%-1.86M

412.66%247K

-48.27%1.42M

---79K

--2.75M

----

Impairment and provision

31.57%-11.71M

-185.88%-9.69M

69.62%-17.11M

--11.28M

-26,983.17%-56.33M

----

---208K

----

-Other impairment is provision

31.57%-11.71M

-185.88%-9.69M

69.62%-17.11M

--11.28M

-26,983.17%-56.33M

----

---208K

----

Special items of operating profit

-163.13%-31.63M

11.75%-4.93M

22.26%-12.02M

35.49%-5.58M

25.30%-15.46M

36.00%-8.66M

-48.85%-20.7M

-81.98%-13.52M

-43.32%-13.91M

-66.84%-7.43M

Operating profit

-29.75%-40.48M

-385.02%-12.22M

41.01%-31.2M

221.44%4.29M

-506.72%-52.88M

62.55%-3.53M

-209.57%-8.72M

-133.06%-9.43M

40.82%7.96M

51.36%-4.04M

Financing cost

16.63%-4.9M

16.54%-2.55M

-1.54%-5.88M

13.34%-3.06M

21.61%-5.79M

13.48%-3.53M

8.86%-7.39M

1.50%-4.08M

-47.23%-8.11M

-135.93%-4.14M

Earning before tax

-22.40%-45.38M

-1,303.99%-14.77M

36.81%-37.08M

117.38%1.23M

-264.36%-58.67M

47.72%-7.06M

-10,635.33%-16.1M

-64.97%-13.51M

-204.17%-150K

18.70%-8.19M

Tax

----

13.25%-2.69M

67.24%-248K

-100.45%-3.1M

8.80%-757K

60.06%-1.54M

41.22%-830K

-48.41%-3.87M

-51.18%-1.41M

After-tax profit from continuing operations

-14.13%-45.38M

-1,608.99%-14.77M

35.63%-39.76M

112.52%979K

-250.02%-61.77M

45.47%-7.82M

-339.42%-17.65M

-49.35%-14.34M

-63.19%-4.02M

12.77%-9.6M

Earning after tax

-14.13%-45.38M

-1,608.99%-14.77M

35.63%-39.76M

112.52%979K

-250.02%-61.77M

45.47%-7.82M

-339.42%-17.65M

-49.35%-14.34M

-63.19%-4.02M

12.77%-9.6M

Minority profit

90.10%-1.85M

42.25%-1.29M

20.98%-18.64M

9.64%-2.23M

-139.42%-23.59M

63.68%-2.47M

-9.56%-9.85M

-323.74%-6.8M

-98.78%-8.99M

-75.41%-1.61M

Profit attributable to shareholders

-106.12%-43.53M

-519.93%-13.48M

44.68%-21.12M

160.04%3.21M

-389.84%-38.18M

29.02%-5.35M

-256.60%-7.79M

5.74%-7.54M

141.25%4.98M

20.77%-7.99M

Basic earnings per share

-20.59%-0.0451

-361.90%-0.0165

56.05%-0.0374

152.94%0.0063

-389.08%-0.0851

29.17%-0.0119

-256.76%-0.0174

5.62%-0.0168

141.30%0.0111

20.89%-0.0178

Diluted earnings per share

-20.59%-0.0451

-361.90%-0.0165

56.05%-0.0374

152.94%0.0063

-389.08%-0.0851

29.17%-0.0119

-256.76%-0.0174

5.62%-0.0168

141.30%0.0111

20.89%-0.0178

Currency Unit

HKD

Accounting Standards

HKAS

Auditor

National Health Accounting Firm Co., Ltd.

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	26.11%51.31M	33.19%25.45M	-39.87%40.68M	-37.41%19.1M	7.40%67.66M	-4.14%30.52M	-10.72%63M	10.92%31.84M	39.24%70.56M	146.07%28.71M
Operating income	26.11%51.31M	33.19%25.45M	-39.87%40.68M	-37.41%19.1M	7.40%67.66M	-4.14%30.52M	-10.72%63M	10.92%31.84M	39.24%70.56M	146.07%28.71M
Cost of sales	-2,196.34%-17.57M	---8.44M	---765K	----	----	----	----	----	----	----
Operating expenses	-2,196.34%-17.57M	-8.44M	-765K
Gross profit	-15.48%33.74M	17.01M	39.92M
Employee expense	-7.58%-17.15M	13.03%-7.25M	10.04%-15.94M	23.01%-8.33M	17.90%-17.72M	5.17%-10.82M	-1.14%-21.59M	-1.77%-11.41M	-47.12%-21.34M	-66.18%-11.21M
Depreciation and amortization	42.88%-13.72M	39.78%-7.37M	17.61%-24.03M	17.49%-12.23M	4.85%-29.16M	8.79%-14.82M	-1.78%-30.65M	-15.23%-16.25M	-44.62%-30.11M	-60.69%-14.11M
Revaluation surplus	----	----	-7.94%-2.01M	-81.38%46K	-231.08%-1.86M	412.66%247K	-48.27%1.42M	---79K	--2.75M	----
-Changes in the fair value of financial assets	----	----	-7.94%-2.01M	-81.38%46K	-231.08%-1.86M	412.66%247K	-48.27%1.42M	---79K	--2.75M	----
Impairment and provision	31.57%-11.71M	-185.88%-9.69M	69.62%-17.11M	--11.28M	-26,983.17%-56.33M	----	---208K	----	----	----
-Other impairment is provision	31.57%-11.71M	-185.88%-9.69M	69.62%-17.11M	--11.28M	-26,983.17%-56.33M	----	---208K	----	----	----
Special items of operating profit	-163.13%-31.63M	11.75%-4.93M	22.26%-12.02M	35.49%-5.58M	25.30%-15.46M	36.00%-8.66M	-48.85%-20.7M	-81.98%-13.52M	-43.32%-13.91M	-66.84%-7.43M
Operating profit	-29.75%-40.48M	-385.02%-12.22M	41.01%-31.2M	221.44%4.29M	-506.72%-52.88M	62.55%-3.53M	-209.57%-8.72M	-133.06%-9.43M	40.82%7.96M	51.36%-4.04M
Financing cost	16.63%-4.9M	16.54%-2.55M	-1.54%-5.88M	13.34%-3.06M	21.61%-5.79M	13.48%-3.53M	8.86%-7.39M	1.50%-4.08M	-47.23%-8.11M	-135.93%-4.14M
Earning before tax	-22.40%-45.38M	-1,303.99%-14.77M	36.81%-37.08M	117.38%1.23M	-264.36%-58.67M	47.72%-7.06M	-10,635.33%-16.1M	-64.97%-13.51M	-204.17%-150K	18.70%-8.19M
Tax	----	----	13.25%-2.69M	67.24%-248K	-100.45%-3.1M	8.80%-757K	60.06%-1.54M	41.22%-830K	-48.41%-3.87M	-51.18%-1.41M
After-tax profit from continuing operations	-14.13%-45.38M	-1,608.99%-14.77M	35.63%-39.76M	112.52%979K	-250.02%-61.77M	45.47%-7.82M	-339.42%-17.65M	-49.35%-14.34M	-63.19%-4.02M	12.77%-9.6M
Earning after tax	-14.13%-45.38M	-1,608.99%-14.77M	35.63%-39.76M	112.52%979K	-250.02%-61.77M	45.47%-7.82M	-339.42%-17.65M	-49.35%-14.34M	-63.19%-4.02M	12.77%-9.6M
Minority profit	90.10%-1.85M	42.25%-1.29M	20.98%-18.64M	9.64%-2.23M	-139.42%-23.59M	63.68%-2.47M	-9.56%-9.85M	-323.74%-6.8M	-98.78%-8.99M	-75.41%-1.61M
Profit attributable to shareholders	-106.12%-43.53M	-519.93%-13.48M	44.68%-21.12M	160.04%3.21M	-389.84%-38.18M	29.02%-5.35M	-256.60%-7.79M	5.74%-7.54M	141.25%4.98M	20.77%-7.99M
Basic earnings per share	-20.59%-0.0451	-361.90%-0.0165	56.05%-0.0374	152.94%0.0063	-389.08%-0.0851	29.17%-0.0119	-256.76%-0.0174	5.62%-0.0168	141.30%0.0111	20.89%-0.0178
Diluted earnings per share	-20.59%-0.0451	-361.90%-0.0165	56.05%-0.0374	152.94%0.0063	-389.08%-0.0851	29.17%-0.0119	-256.76%-0.0174	5.62%-0.0168	141.30%0.0111	20.89%-0.0178
Currency Unit	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Auditor	--	--	National Health Accounting Firm Co., Ltd.	--	National Health Accounting Firm Co., Ltd.	--	National Health Accounting Firm Co., Ltd.	--	National Health Accounting Firm Co., Ltd.	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"